Anastrozole

Back to search

Molecule Structure

Scientific Name

Anastrozole

Description of the Drug

Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01217

Brand Name(s)

Anastrozole, Arimidex, Nastrosa

Company Owner(s)

Cipla Ltd, Picket Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Impax Laboratories Inc, Fresenius Kabi Usa Llc, Sun Pharmaceutical Industries Ltd., Accord Healthcare Inc, Ani Pharmaceuticals Inc, Sandoz Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cytochrome P450 19A1 SINGLE PROTEIN INHIBITOR CHEMBL1978

Unichem Links

SureChEMBL SCHEMBL9726
PharmGKB PA448432
Human Metabolome Database HMDB0015348
DrugBank DB01217
PubChem: Thomson Pharma 14751420
PubChem 2187
Mcule MCULE-3029589501
LINCS LSM-5631
Nikkaji J592.428F
BindingDB 10015
EPA CompTox Dashboard DTXSID9022607
DrugCentral 210
Brenda 19102 219759
ChemicalBook CB3121715
Guide to Pharmacology 5137
rxnorm ANASTROZOLE ARIMIDEX
PubChem: Drugs of the Future 12014321
KEGG Ligand C08159
ChEBI 2704
ZINC ZINC000000000941